Cravens & CO Advisors, LLC Abb Vie Inc. Transaction History
Cravens & CO Advisors, LLC
- $135 Billion
- Q2 2024
A detailed history of Cravens & CO Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Cravens & CO Advisors, LLC holds 6,903 shares of ABBV stock, worth $1.38 Million. This represents 0.88% of its overall portfolio holdings.
Number of Shares
6,903
Previous 6,388
8.06%
Holding current value
$1.38 Million
Previous $1.16 Billion
1.78%
% of portfolio
0.88%
Previous 0.97%
Shares
7 transactions
Others Institutions Holding ABBV
# of Institutions
3,773Shares Held
1.28BCall Options Held
13MPut Options Held
9.82M-
Vanguard Group Inc Valley Forge, PA171MShares$34.2 Billion0.57% of portfolio
-
Black Rock Inc. New York, NY136MShares$27.4 Billion0.54% of portfolio
-
State Street Corp Boston, MA77.8MShares$15.6 Billion0.59% of portfolio
-
Jpmorgan Chase & CO New York, NY53.6MShares$10.7 Billion0.81% of portfolio
-
Capital International Investors Los Angeles, CA38.6MShares$7.74 Billion1.4% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $354B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...